✦ LIBER ✦

Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia

✍ Scribed by Robert L. Dufresne; David J. Kass; Robert E. Becker

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 552 KB
Volume: 12
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.430120308

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of thiothixene in agitated, demented nursing home patients'

✍ Sanford I. Finkel; John S. Lyons; Rachel L. Anderson; Kathleen Sherrell; John Da 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

The therapeutic efficacy of thiothixene in the treatment of behaviorally agitated dementia nursing home patients was studied in a double-blind, randomized, placebo-controlled clinical trial. Thirty-three subjects were randomized for thiothixene (dose range: 0.25-18 mg) or placebo treatment over an 1

Bupropion SR in the naturalistic treatme

Bupropion SR in the naturalistic treatment of elderly patients with major depression

✍ David C. Steffens; P. Murali Doraiswamy; Douglas R. McQuoid 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## Abstract ## Introduction Bupropion immediate release (IR) and bupropion sustained release (SR) are frequently used to treat geriatric depression, as they have few cardiovascular, gastrointestinal and sexual adverse effects. We sought to examine the efficacy and dosing patterns of bupropion in a

A double-blind comparison of melperone a

A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS

✍ Lars Bjerkenstedt; Christer Härnryd; Veronika Grimm; Bo Gullberg; Göran Sedvall 📂 Article 📅 1978 🏛 Springer-Verlag 🌐 English ⚖ 837 KB

Eighty-one women with psychosis of schizophrenic and paranoid type were assigned to a double-blind study comparing the clinical effects of melperone (100 mg X 3) and thiothixene (10 mg X 3). The antipsychotic effect was evaluated by clinical rating according to the CPRS and the NOSIE-30 scales befor

Cianopramine and amitriptyline in the tr

Cianopramine and amitriptyline in the treatment of depressed patients — a placebo-controlled study

✍ L. Hormazabal; L. M. O. Omer; S. Ismail 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 330 KB

3-Cyano-imipramine (cianopramine) is a potent and selective inhibitor of serotonin uptake into synaptosomes. In a double-blind trial, 60 patients with various types of depression fulfilling the DSM-III criteria of depressive episodes were treated with either cianopramine (n=20, mean daily dose 3.3\_

Hippocampal volumetrics in treatment-res

Hippocampal volumetrics in treatment-resistant depression and schizophrenia: The devil's in De-Tail

✍ Jerome J. Maller; Zafiris J. Daskalakis; Richard H.S. Thomson; Melissa Daigle; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

## Abstract Studies of patients with major depressive disorder (MDD) and schizophrenia (SCH) have revealed reduced hippocampal volumes, but findings have been inconsistent due to sample and measurement differences. The current study sought to measure this structure in a large sample of MDD, SCH, an

Comprehensive high-performance liquid ch

Comprehensive high-performance liquid chromatographic methodology for the determination of thiothixene in bulk drug, finished product, and dissolution testing samples

✍ Gregory Severin 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB